Satraplatin: A new treatment option for patients with hormone refractory prostate cancer.

被引：0
|
作者：
Nathan, FE
Sternberg, C
Sartor, O
Petrylak, D
Witjes, F
Wosikowski, K
Petrone, ME
Rozencweig, M
机构：
[1] GPC Biotech Inc, Princeton, NJ USA
[2] San Camillo Hosp, Rome, Italy
[3] Forlanini Hosp, Rome, Italy
[4] LSU, Sch Med, New Orleans, LA USA
[5] Columbia Presbyterian Med Ctr, New York, NY 10032 USA
[6] Acad Ziekenhuis, Nijmegen, Netherlands
[7] GPC Biotech AG, Munich, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：453S / 453S
页数：1
相关论文
共 50 条
  • [31] Management of patients with hormone refractory prostate cancer
    Muthuramalingam, SR
    Patel, K
    Protheroe, A
    CLINICAL ONCOLOGY, 2004, 16 (08) : 505 - 516
  • [32] New therapeutic approaches for hormone refractory prostate cancer. Study AP46/06
    Rexer, H.
    ONKOLOGE, 2007, 13 (04): : 363 - 364
  • [33] Neuroendocrine markers as predictor of octreotide acetate therapy in patients with hormone-refractory prostate cancer.
    Acosta, S
    Kälkner, KM
    Thorsson, O
    Fredriksson, M
    Nilsson, A
    Gustavsson, B
    Elingsbo, M
    Stridsberg, M
    Abrahamsson, PA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 443S - 443S
  • [34] Are there any treatment option for metastatic prostate cancer refractory to docetaksel?
    Beduk, Yasar
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2011, 10 (02): : 85 - 89
  • [35] Phase I/II study of taxane and estramustine with samarium in patients with hormone refractory prostate cancer.
    Arnsmeier, SL
    Spies, S
    Shervin, D
    Pins, M
    Bergan, RC
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 439S - 439S
  • [36] Etoposide and estramustine in previously treated hormone-refractory prostate cancer.
    Pavese, I.
    Di Palma, M.
    Mazzoli, M.
    Burattini, E.
    Satta, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [37] A role of somatostatin analogues in the treatment of patients with hormone-refractory prostate cancer
    Alekseev, B. Ya.
    Kaprin, A. D.
    Nyushko, K. M.
    ONKOUROLOGIYA, 2011, 7 (02): : 84 - 87
  • [38] Is there a role for platinum chemotherapy in the treatment of patients with hormone-refractory prostate cancer?
    Oh, William K.
    Tay, Miah-Hiang
    Huang, Jiaoti
    CANCER, 2007, 109 (03) : 477 - 486
  • [39] Multimodality treatment in hormone-refractory prostate cancer patients with bone metastases
    Marnix G. E. H. Lam
    Bernard A. Zonnenberg
    European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 : 1394 - 1395
  • [40] Multimodality treatment in hormone-refractory prostate cancer patients with bone metastases
    Lam, Marnix G. E. H.
    Zonnenberg, Bernard A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 (07) : 1394 - 1395
12345